Sydney, Australia (CU)_ MIM Software Inc. has entered into a collaboration with GenesisCare, a renowned worldwide provider of integrated cancer treatment, to expand global patient access to world-class treatment. The clinical teams of GenesisCare provide cancer care to over 400,000 patients at over 440 locations around the United States, Australia, the United Kingdom, and Spain.
GenesisCare and MIM Software formed a strategic alliance with the primary goal of enhancing cancer patients results by improving the Radiation Oncology and Molecular Therapy treatment planning ecosystems. Andy Nelson, CEO of MIM Software, expressed hopes over the collaboration. He said, “Our partnership with GenesisCare exemplifies MIM Software’s commitment to delivering scalable technologies and solutions that can support, sustain, and impact patients’ lives on a global scale”.
MIM Software will provide, deploy, and assist MIM Premier®, MIM SurePlanTM MRT, and a full set of automation and artificial intelligence platforms throughout GenesisCare’s global treatment facilities. The collaboration is based on GenesisCare’s objective of fully optimizing and automating treatment delivery to a new height, for which it will utilize MIM Software’s experience and world-standard imaging technologies to enable data-driven decision-making.
Kanak Chatterjee, Vice President of Business Development at MIM Software, expressed optimism over the partnership. He said, “Providing a technology uplift on such a scale opens the door to continuous access to collaborative innovations that patients can benefit from almost instantaneously, regardless of where they are geographically located”.
Keith Hansen, Chief Strategy & Corporate Development Officer at GenesisCare, expressed delight over the partnership. He said, “We are delighted to expand our partnership with MIM Software, building on the strong foundations and success with the solution in our clinics in Australia and Europe”.
Keith Hansen also discussed the benefits of incorporating the techniques of MIM Software into GenesisCare’s cancer treatments. He added, “Over the past 18 months, we have invested significant time and capital in upgrading and installing innovative treatment technologies in our centers across the United States, Australia, United Kingdom, and Spain, so that our patients can access world-class cancer care at their doorstep. By implementing MIM Software into our clinics, we will be able to fully realize the benefits of these advanced technologies and provide highly advanced stereotactic treatment techniques that deliver the best possible outcomes for our patients.”
